COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,633 Articles (22,913 medRxiv, 8,720 bioRxiv)

Most recent first Previous |  Page 1581: Articles 15801-15810  | Next

Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response
Dickey, T. H., Tang, W. K., Butler, B., Ouahes, T., Orr-Gonzalez, S., Salinas, N. D., Lambert, L. E., Tolia, N. H.
10.1101/2021.05.09.443238 — Posted: 2021-05-10
Following the Trail of One Million Genomes: Footprints of SARS-CoV-2 Adaptation to Humans
Akther, S., Bezrucenkovas, E., Li, L., Sulkow, B., Di, L., Pante, D., Martin, C. L., Luft, B. J., Qiu, W.
10.1101/2021.05.07.443114 — Posted: 2021-05-10
In-solution buffer-free digestion for the analysis of SARS-CoV-2 RBD proteins allows a full sequence coverage and detection of post-translational modifications in a single ESI-MS spectrum
Espinosa, L. A., Ramos, Y., Andujar, I., Torres, E. O., Cabrera, G., Martin, A., Gonzalez, D., Chinea, G., Becquet, M., Gonzalez, I., Canaan-Haden, C., Nelson, E., Rojas, G., Perez-Masson, B., Perez-Martinez, D., Boggiano, T., Palacio, J., Lozada-Chang, S. L., Hernandez, L., de la Luz, K. R., Markku, S., Marika, V., Valdes-Balbin, Y., Santana-Medero, D., G. Rivera, D., Verez Bencomo, V., Emalfarb, M., Tchelet, R., Guillen, G., Limonta, M., Pimentel, E., Ayala, M., Besada, V., Gonzalez, L. J.
10.1101/2021.05.10.443404 — Posted: 2021-05-10
Binding of SARS-CoV-2 fusion peptide to host membranes
Schaefer, S. L., Jung, H., Hummer, G.
10.1101/2021.05.10.443474 — Posted: 2021-05-10
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
Joyce, M. G., Modjarrad, K.
10.1101/2021.05.09.443331 — Posted: 2021-05-10 Discussion: Offsite
Nanopore dwell time analysis permits sequencing and conformational assignment of pseudouridine in SARS-CoV-2
Burrows, C. J., Mathewson, N. J., Fleming, A. M.
10.1101/2021.05.10.443494 — Posted: 2021-05-10
Rapid inactivation of SARS-CoV-2 variants by continuous and intermittent irradiation with a deep-ultraviolet light-emitting diode (DUV-LED) device
Inagaki, H., Saito, A., Kaneko, C., Sugiyama, H., Okabayashi, T., Fujimoto, S.
10.1101/2021.05.10.443422 — Posted: 2021-05-10
SARS-COV-2 Recombinant Receptor-Binding-Domain (RBD) Induces Neutralising Antibodies Against Variant Strains of SARS-CoV-2 and SARS-CoV-1
Law, J. L. M., Logan, M., Joyce, M., Landi, A., Hockman, D., Crawford, K., Johnson, J., LaChance, G., Saffran, H., Shields, J., Hobart, E., Brassard, R., Arutyunova, E., Pabbaraju, K., Croxen, M., Tipples, G., Lemieux, M. J., Tyrrell, D. L., Houghton, M.
10.1101/2021.05.10.443438 — Posted: 2021-05-10
High Dose Convalescent Plasma in COVID-19: Results from the randomized Trial CAPSID
Koerper, S., Weiss, M., Zickler, D., Wiesmann, T., Zacharowski, K., Corman, V. M., Gruener, B., Ernst, L., Spieth, P., Lepper, P. M., Bentz, M., Zinn, S., Paul, G., Kalbhenn, J., Dollinger, M., Rosenberger, P., Kirschning, T., Thiele, T., Appl, T., Mayer, B., Schmidt, M., Drosten, C., Wulf, H., Kruse, J. M., Jungwirth, B., Seifried, E., Schrezenmeier, H.
10.1101/2021.05.10.21256192 — Posted: 2021-05-10
A population-level analysis of the protective effects of androgen deprivation therapy against COVID-19 disease incidence and severity
Lee, K., Heberer, K., Gao, A., Becker, D. J., Loeb, S., Makarov, D., Gulanski, B., Duvall, S., Aslan, M., Lee, J., Hauger, R., Shih, M.-C., Lynch, J., Rettig, M.
10.1101/2021.05.10.21255146 — Posted: 2021-05-10 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).